| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.52M | $2.16M | - | |
| CEO | 976.1K | $1.39M | - | |
| Other | 60.0K | $85.2K | - | |
| Other | 46.5K | $66.0K | - | |
| Dir | 29.8K | $42.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 | Smith Stan | Director | Buy | 5,742 | $3.23 | $18,532.80 | +0.5% | -31.0% | -46.1% | |
| Mar 16, 2023 | Guerrero Ramiro | Director | Buy | 1,333 | $3.64 | $4,852.12 | +0.4% | -34.4% | -60.5% | |
| Mar 13, 2023 | Luput Cristian | Director | Buy | 8,382 | $4.02 | $33,684.18 | +1.5% | -34.8% | -65.4% | |
| Mar 10, 2023 | Guerrero Ramiro | Director | Buy | 1,500 | $3.98 | $5,970.00 | +0.3% | -38.2% | -66.8% | |
| Mar 9, 2023 | Smith Stan | Director | Buy | 3,582 | $4.03 | $14,435.46 | +0.7% | -41.1% | -66.8% | |
| Mar 9, 2023 | Luput Cristian | Director | Buy | 2,741 | $4.03 | $11,059.66 | +0.5% | -41.1% | -66.8% | |
| Mar 8, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,581 | $4.21 | $6,656.01 | +0.2% | -41.5% | -65.9% | |
| Mar 8, 2023 | Smith Stan | Director | Buy | 5,037 | $4.21 | $21,214.23 | +0.5% | -41.5% | -65.9% | |
| Mar 7, 2023 | Luput Cristian | Director | Buy | 2,215 | $4.23 | $9,374.72 | +0.4% | -45.3% | -65.8% | |
| Mar 7, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,983 | $4.24 | $8,407.92 | +0.1% | -45.3% | -65.8% |